AAAAAA
Results: 1-25/3599
Authors:
MEHTA J
SINGHAL S
Citation: J. Mehta et S. Singhal, GRAFT-VERSUS-MYELOMA, Bone marrow transplantation, 22(9), 1998, pp. 835-843
Authors:
CHARRIER S
CHASSAGNE J
CURE H
BAY JO
COMMUNAL Y
PORTEFAIX G
FERRIERE JP
BETAIL G
PLAGNE R
CHOLLET P
Citation: S. Charrier et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER INDUCTION CHEMOTHERAPY RUBICIN-VINORELBINE-CYCLOPHOSPHAMIDE-FLUOROURACIL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN BREAST-CANCER, Bone marrow transplantation, 22(9), 1998, pp. 845-851
Authors:
LIE AKW
HUI CH
RAWLING T
DYSON PG
THORP D
BENIC J
RAWLING CM
TOOGOOD I
HORVATH N
SIMMONS PJ
TO LB
Citation: Akw. Lie et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) DOSE-DEPENDENT EFFICACYIN PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN PATIENTS WHO HAD FAILEDINITIAL MOBILIZATION WITH CHEMOTHERAPY AND G-CSF, Bone marrow transplantation, 22(9), 1998, pp. 853-857
Authors:
CLARK RE
BRAMMER CG
Citation: Re. Clark et Cg. Brammer, PREVIOUS TREATMENT PREDICTS THE EFFICIENCY OF BLOOD PROGENITOR-CELL MOBILIZATION - VALIDATION OF A CHEMOTHERAPY SCORING SYSTEM, Bone marrow transplantation, 22(9), 1998, pp. 859-863
Authors:
LINKER CA
RIES CA
DAMON LE
RUGO HS
WOLF JL
Citation: Ca. Linker et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA USING 4-HYDROPEROXYCYCLOPHOSPHAMIDE-PURGED BONE-MARROW AND THE BUSULFAN ETOPOSIDE PREPARATIVE REGIMEN - A FOLLOW-UP REPORT/, Bone marrow transplantation, 22(9), 1998, pp. 865-872
Authors:
SHERER Y
SHOENFELD Y
Citation: Y. Sherer et Y. Shoenfeld, AUTOIMMUNE-DISEASES AND AUTOIMMUNITY POST-BONE MARROW TRANSPLANTATION, Bone marrow transplantation, 22(9), 1998, pp. 873-881
Authors:
LEE JH
LEE KH
KIM S
LEE JS
KIM WK
PARK CJ
CHI HS
KIM SH
Citation: Jh. Lee et al., RELEVANCE OF PROTEIN-C AND PROTEIN-S, ANTITHROMBIN-III, VON-WILLEBRAND-FACTOR, AND FACTOR-VIII FOR THE DEVELOPMENT OF HEPATIC VENOOCCLUSIVEDISEASE IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION- A PROSPECTIVE-STUDY, Bone marrow transplantation, 22(9), 1998, pp. 883-888
Authors:
CHILDS R
SANCHEZ C
ENGLER H
PREUSS J
ROSENFELD S
DUNBAR C
VANRHEE F
PLANTE M
PHANG S
BARRETT AJ
Citation: R. Childs et al., HIGH-INCIDENCE OF ADENOVIRUS-INDUCED AND POLYOMAVIRUS-INDUCED HEMORRHAGIC CYSTITIS IN BONE-MARROW ALLOTRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY FOLLOWING T-CELL DEPLETION AND CYCLOSPORINE, Bone marrow transplantation, 22(9), 1998, pp. 889-893
Authors:
RUFER N
STAROBINSKI M
CHAPUIS B
GRATWOHL A
JEANNET M
HELG C
ROOSNEK E
Citation: N. Rufer et al., CLINICAL CONSEQUENCES OF SENSITIZATION TO MINOR HISTOCOMPATIBILITY ANTIGENS BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(9), 1998, pp. 895-898
Authors:
MANTEIGA R
MARTINO R
SUREDA A
LABEAGA R
BRUNET S
SIERRA J
RABELLA N
Citation: R. Manteiga et al., CYTOMEGALOVIRUS PP65 ANTIGENEMIA-GUIDED PREEMPTIVE TREATMENT WITH GANCICLOVIR AFTER ALLOGENEIC STEM TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 22(9), 1998, pp. 899-904
Authors:
KEOGH F
ORIORDAN J
MCNAMARA C
DUGGAN C
MCCANN SR
Citation: F. Keogh et al., PSYCHOSOCIAL ADAPTATION OF PATIENTS AND FAMILIES FOLLOWING BONE-MARROW TRANSPLANTATION - A PROSPECTIVE, LONGITUDINAL-STUDY, Bone marrow transplantation, 22(9), 1998, pp. 905-911
Authors:
HASSAN Z
NILSSON C
HASSAN M
Citation: Z. Hassan et al., LIPOSOMAL BUSULFAN - BIOAVAILABILITY AND EFFECT ON BONE-MARROW IN MICE, Bone marrow transplantation, 22(9), 1998, pp. 913-918
Authors:
KOSTARIDOU S
LADIS V
KATTAMIS A
LARAS A
HADZIYANNIS SJ
Citation: S. Kostaridou et al., HBEAG-NEGATIVE HEPATITIS-B IN A PREVIOUSLY THALASSEMIC PATIENT DURINGIMMUNOSUPPRESSIVE THERAPY FOR CHRONIC GVHD, Bone marrow transplantation, 22(9), 1998, pp. 919-921
Authors:
HIRAYAMA M
AZUMA E
KUMAMOTO T
QI J
KOBAYASHI M
KOMADA Y
INUI T
MIYAKE M
MUGISHIMA H
HAMAZAKI M
SAKURAI M
Citation: M. Hirayama et al., LATE-ONSET UNILATERAL RENAL DYSFUNCTION COMBINED WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND BRONCHIAL-ASTHMA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN A CHILD, Bone marrow transplantation, 22(9), 1998, pp. 923-926
Authors:
MATSUMOTO T
AMAMOTO N
KONDOH T
NAKAYAMA M
TAKAYANAGI T
TSUJI Y
Citation: T. Matsumoto et al., COMPLETE-TYPE DIGEORGE-SYNDROME TREATED BY BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(9), 1998, pp. 927-930
Authors:
SUZUKI N
KUDOH T
MIZUE N
WATANABE J
IKEHATA M
TATENO M
OOGURO H
CHIBA S
Citation: N. Suzuki et al., CMV RETINITIS AFTER CESSATION OF GANCICLOVIR THERAPY FOR CMV ANTIGENEMIA IN AN UNRELATED BMT RECIPIENT, Bone marrow transplantation, 22(9), 1998, pp. 931-932
Authors:
SASTRY PSRK
POWLES RL
Citation: Psrk. Sastry et Rl. Powles, THALIDOMIDE FOR CHRONIC GVHD, Bone marrow transplantation, 22(9), 1998, pp. 933-934
Authors:
SARRA J
VIVANCOS P
SOLA R
GRANENA A
Citation: J. Sarra et al., MULTIPLE RISK-FACTORS FOR HIGH-DOSE CHEMOTHERAPY, Bone marrow transplantation, 22(9), 1998, pp. 933-933
Authors:
KAMI M
OGAWA S
MITANI K
HIRAI H
Citation: M. Kami et al., THALIDOMIDE FOR CHRONIC GVHD - REPLY, Bone marrow transplantation, 22(9), 1998, pp. 934-934
Authors:
VANCE E
GEORGE S
GUINAN EC
WHEELER C
ANTIN JH
AMBROSINO DM
MOLRINE DC
Citation: E. Vance et al., COMPARISON OF MULTIPLE IMMUNIZATION SCHEDULES FOR HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE AND TETANUS TOXOID VACCINES FOLLOWING BONE-MARROWTRANSPLANTATION, Bone marrow transplantation, 22(8), 1998, pp. 735-741
Authors:
MONTAGNA D
LOCATELLI F
CALCATERRA V
COMOLI P
MORETTA A
GIORGIANI G
ZECCA M
BONETTI F
GIRALDI E
RONDINI G
MACCARIO R
Citation: D. Montagna et al., DOES THE EMERGENCE AND PERSISTENCE OF DONOR-DERIVED LEUKEMIA-REACTIVECYTOTOXIC T-LYMPHOCYTES PROTECT PATIENTS GIVEN AN ALLOGENEIC BMT FROMRECURRENCE - RESULTS OF A PRELIMINARY-STUDY, Bone marrow transplantation, 22(8), 1998, pp. 743-750
Authors:
KANDA Y
TANAKA Y
SHIRAKAWA K
YATOMI T
NAKAMURA N
KAMI M
SAITO T
IZUTSU K
ASAI T
YUJI K
OGAWA S
HONDA H
MITANI K
CHIBA S
YAZAKI Y
HIRAI H
Citation: Y. Kanda et al., INCREASED SOLUBLE FAS-LIGAND IN SERA OF BONE-MARROW TRANSPLANT RECIPIENTS WITH ACUTE GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 22(8), 1998, pp. 751-754
Authors:
CARLENS S
RINGDEN O
REMBERGER M
LONNQVIST B
HAGGLUND H
KLAESSON S
MATTSSON J
SVAHN BM
WINIARSKI J
LJUNGMAN P
ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761
Authors:
LOWENTHAL RM
FABERES C
MARIT G
BOIRON JM
CONYMAKHOUL P
PIGNEUX A
AGAPE P
VEZON G
BOUZGAROU R
DAZEY B
FIZET D
BERNARD P
LACOMBE F
REIFFERS J
Citation: Rm. Lowenthal et al., FACTORS INFLUENCING HEMATOPOIETIC RECOVERY FOLLOWING CHEMOTHERAPY-MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FORHEMATOLOGICAL MALIGNANCIES - A RETROSPECTIVE ANALYSIS OF A 10-YEAR SINGLE INSTITUTION EXPERIENCE, Bone marrow transplantation, 22(8), 1998, pp. 763-770
Authors:
HILDEBRANDT M
BLASER F
BEYER J
SIEGERT W
MAPARA MY
HUHN D
SALAMA A
Citation: M. Hildebrandt et al., DETECTION OF TUMOR-CELLS IN PERIPHERAL-BLOOD SAMPLES FROM PATIENTS WITH GERM-CELL TUMORS USING IMMUNOCYTOCHEMICAL AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION TECHNIQUES, Bone marrow transplantation, 22(8), 1998, pp. 771-775